Heron Therapeutics's total assets for Q4 2025 were $255.88M, an increase of 2.78% from the previous quarter. HRTX total liabilities were $241.54M for the fiscal quarter, a 3.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.